Latest Breaking News On - Oncodermatology program - Page 1 : comparemela.com

Aptar Digital Health Expands Oncology Clinical Advisory Board

Crystal Lake, Illinois, November 21, 2023 - Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs) and disease management solutions, today announced the expansion of its Oncology Clinical Advisory Board. Comprised of leading clinical, oncology and digita.

University of miamiUnited statesNew yorkThomas jefferson universityMemorial sloan kettering cancer centerCrystal lakeComunidad autonoma de catalunaUnited kingdomAciara jacksonGenevieve dorsayAptar pharmaPierre leurentAptar pharma digital healthUniversity of bresciaHead of the neuroimmunology centerDigital health expert

Kintara Therapeutics (KTRA) Approved to Proceed with REM-001 Study

Kintara Therapeutics (KTRA) Approved to Proceed with REM-001 Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoMarioe lacoutureRoberte hoffmanGlobal coalition for adaptive researchNational cancer instituteCompany current reports on formKintara therapeutics incDrug administrationCompany quarterly reports on formCompany annual report on formOncodermatology programStudy may proceedUnited states foodCutaneous metastatic breast cancerInvestigational new drug

Kintara Therapeutics Receives Study May Proceed Letter from the FDA for REM-001 for Cutaneous Metastatic Breast Cancer

/PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid.

United statesSan diegoJules abrahamMarioe lacoutureRoberte hoffmanGlobal coalition for adaptive researchNational cancer instituteCompany current reports on formDrug administrationKintara therapeutics incCompany quarterly reports on formCompany annual report on formOncodermatology programKintara therapeuticsStudy may proceedUnited states food

Rubedo Life Sciences Announces Expansion of Scientific Advisory Board

Rubedo Life Sciences Announces Expansion of Scientific Advisory Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMemorial sloan kettering cancer centerBoston universityDana farber cancer instituteState university of new york at stony brookLidia schapiraMark pegramCastle connollyMarco quartaMario lacoutureJudith judy campisiCory hogaboamFrancesca grisoniJudith campisiPaul insel

Lutris Pharma Doses First U S Patients in Phase 2 Trial of LUT014 -- a Topical Gel for the Reduction of Dose-Limiting Acneiform Lesions -- in Metastatic Colorectal Cancer Patients Treated with EGFR Inhibitor Therapy

Lutris Pharma Doses First U S Patients in Phase 2 Trial of LUT014 -- a Topical Gel for the Reduction of Dose-Limiting Acneiform Lesions -- in Metastatic Colorectal Cancer Patients Treated with EGFR Inhibitor Therapy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMemorial sloan kettering cancer centerKostenloser wertpapierhandelNoa shelachMichael millerMarioe lacoutureLutris pharmaRx communications groupPatient recruitmentIsrael continuesChief executive officerOncodermatology programEpidermal growth factor receptorB raf inhibitorபுதியது யார்க்